Pages that link to "Q34589157"
Jump to navigation
Jump to search
The following pages link to What is new in uremic toxicity? (Q34589157):
Displaying 50 items.
- N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin (Q28069862) (← links)
- Uremic toxins: some thoughts on acrolein and spermine (Q30244334) (← links)
- Elevated serum interleukin-18 level is associated with all-cause mortality in stable hemodialysis patients independently of cardiac dysfunction (Q31152688) (← links)
- An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. (Q33663437) (← links)
- Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations. (Q33869303) (← links)
- The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review (Q34103477) (← links)
- Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine. (Q34789487) (← links)
- Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? (Q34796627) (← links)
- Self-Registration Methods for Increasing Membrane Utilization within Compression-Sealed Microchannel Hemodialysers (Q35018427) (← links)
- Genomic damage in endstage renal disease-contribution of uremic toxins (Q35155634) (← links)
- Thrombosis in the uremic milieu--emerging role of "thrombolome". (Q35532702) (← links)
- New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall'. (Q35534579) (← links)
- Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management (Q35606449) (← links)
- Renal systems biology of patients with systemic inflammatory response syndrome (Q36113202) (← links)
- Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters (Q36250282) (← links)
- Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure (Q36265861) (← links)
- Usefulness of serum interleukin-18 in predicting cardiovascular mortality in patients with chronic kidney disease--systems and clinical approach (Q36376101) (← links)
- What do drug transporters really do? (Q36571217) (← links)
- Oxidative stress, superoxide production, and apoptosis of neutrophils in dogs with chronic kidney disease (Q36709427) (← links)
- SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation (Q37477751) (← links)
- Protein-bound uremic toxins: new insight from clinical studies (Q37954338) (← links)
- Home haemodialysis and uraemic toxin removal: does a happy marriage exist? (Q38038454) (← links)
- Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update (Q38098897) (← links)
- Vascular damage in kidney disease: beyond hypertension (Q38256997) (← links)
- Haemodialysis-induced hypoglycaemia and glycaemic disarrays (Q38409082) (← links)
- Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus (Q38461421) (← links)
- Incremental haemodialysis (Q38514179) (← links)
- Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression. (Q38704835) (← links)
- Why choose high volume online post-dilution hemodiafiltration? (Q38944171) (← links)
- A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue. (Q39021758) (← links)
- Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease (Q39583782) (← links)
- Design, conduct, analysis, and interpretation of clinical studies in patients with impaired kidney function (Q39664155) (← links)
- Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption. (Q41190048) (← links)
- Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease. (Q41683128) (← links)
- Protein-bound P-cresol inhibits human umbilical vein endothelial cell proliferation by inducing cell cycle arrest at G0/G1. (Q42068173) (← links)
- A metabolomic approach to clarifying the effect of AST-120 on 5/6 nephrectomized rats by capillary electrophoresis with mass spectrometry (CE-MS). (Q42366987) (← links)
- Metabolomic profiling of uremic solutes in CKD patients. (Q42976660) (← links)
- Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration (Q43276370) (← links)
- In vitro study of removal of protein-bound toxins (Q43989399) (← links)
- Free p-Cresol Alters Neutrophil Function in Dogs (Q46649759) (← links)
- TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. (Q46800130) (← links)
- New insights into the effect of haemodiafiltration on mortality: the Romanian experience (Q48810257) (← links)
- A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients (Q49140102) (← links)
- Modulation of multidrug resistance-associated proteins function in erythrocytes in glycerol-induced acute renal failure rats (Q51320612) (← links)
- Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats. (Q52575504) (← links)
- Determination of Guanidino Compounds in Serum by Micellar Electrokinetic Capillary Chromatography Using Benzoin as the Derivatizing Reagent (Q58130740) (← links)
- Long‐term serum proteomes are quite similar under high‐ and low‐flux hemodialysis treatment (Q82776621) (← links)
- Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model (Q84417237) (← links)
- Urinary Excretion of N1-methyl-2-pyridone-5-carboxamide and N1-methylnicotinamide in Renal Transplant Recipients and Donors (Q89633188) (← links)
- Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets (Q90264301) (← links)